Cargando…

Cancer immunotherapy‐targeted glypican‐3 or neoantigens

Immune checkpoint inhibitors have ushered in a new era in cancer therapy, although other therapies or combinations thereof are still needed for many patients for whom these drugs are ineffective. In this light, we have identified glypican‐3 an HLA‐24, HLA‐A2 restriction peptide with extreme cancer s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Yasuhiro, Suzuki, Toshihiro, Yoshikawa, Toshiaki, Tsuchiya, Nobuhiro, Sawada, Yu, Endo, Itaru, Nakatsura, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Thematic Section: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834776/ https://www.ncbi.nlm.nih.gov/pubmed/29285841 http://dx.doi.org/10.1111/cas.13485

Ejemplares similares

Next-Generation Cancer Immunotherapy Targeting Glypican-3
por: Shimizu, Yasuhiro, et al.
Publicado: (2019)

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens
por: Kiyotani, Kazuma, et al.
Publicado: (2018)

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
por: Tsuchiya, Nobuhiro, et al.
Publicado: (2017)

A glypican-3-derived peptide vaccine against hepatocellular carcinoma
por: Sawada, Yu, et al.
Publicado: (2012)

Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: An autopsy case
por: Sawada, Yu, et al.
Publicado: (2013)

Identification of an H2-K(b) or H2-D(b) restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide
por: IWAMA, TATSUAKI, et al.
Publicado: (2013)

Plasma and tumoral glypican‐3 levels are correlated in patients with hepatitis C virus‐related hepatocellular carcinoma
por: Shimizu, Yasuhiro, et al.
Publicado: (2019)

Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma
por: Ofuji, Kazuya, et al.
Publicado: (2016)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide
por: TADA, YOSHITAKA, et al.
Publicado: ( 201)

Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
por: SAWADA, YU, et al.
Publicado: (2014)

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer
por: Akazawa, Yu, et al.
Publicado: (2020)

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
por: Karpanen, Terhi, et al.
Publicado: (2017)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery
por: Miura, Masahiro, et al.
Publicado: (2020)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer
por: Oka, Miho, et al.
Publicado: (2021)

Immune‐suppressive effects of interleukin‐6 on T‐cell‐mediated anti‐tumor immunity
por: Tsukamoto, Hirotake, et al.
Publicado: (2017)

Present status and future perspective of peptide‐based vaccine therapy for urological cancer
por: Obara, Wataru, et al.
Publicado: (2018)

Universal Social Protection and Health Care as a Social Common
por: Mestrum, Francine
Publicado: (2020)

Corporate Food Paradigms and Health Crisis: The Image of a Syndemic Crash
por: Salcedo Fidalgo, Hernando
Publicado: (2020)

Radical Approaches During Unusual Circumstances: Intellectual Property Regulation and the COVID-19 Dilemma
por: El Said, Mohammed
Publicado: (2020)

COVID-19 and Private Health: Market and Governance Failure
por: Williams, Owain David
Publicado: (2020)

Politics of International Health in the Bush Administration
por: Waxman, Henry A
Publicado: (2004)

Claiming Health as a Public Good in the Post-COVID-19 Era
por: Abdalla, Salma M., et al.
Publicado: (2020)

Between Tech and Trade, the Digital Turn in Development Policies
por: Al Dahdah, Marine, et al.
Publicado: (2020)

COVID-19 Pandemic Recession and Recovery
por: Jomo, K. S., et al.
Publicado: (2020)

A Volatile Context: A Revisionist Lens on Good Governance
por: Zuber, Robert
Publicado: (2021)

Negotiating Boundaries of Power in the Global Governance for Care
por: Durano, Marina
Publicado: (2021)

Slaying the New Dragons that Threaten Peace: Renewing the UN's ‘Systemic Issues’ Agenda
por: Montes, Manuel F.
Publicado: (2021)

A Trade Agenda for the Right to Food
por: Fakhri, Michael
Publicado: (2021)

Refusal as Radical Care? Moving Beyond Modern Industrial Agriculture
por: Arora, Saurabh, et al.
Publicado: (2021)

Global Food Governance
por: McKeon, Nora
Publicado: (2021)

Re-imagining the UN Committee on World Food Security
por: Guttal, Shalmali
Publicado: (2021)

Towards Building Comprehensive Legal Frameworks for Corporate Accountability in Food Governance
por: Dorado, Daniel, et al.
Publicado: (2021)

On the Non-reception of the Food Systems Summit in Europe
por: van der Ploeg, Jan Douwe
Publicado: (2021)

The Food Systems Summit’s Failure to Address Corporate Power
por: Clapp, Jennifer, et al.
Publicado: (2021)

Global Food Governance
por: McKeon, Nora
Publicado: (2021)

UN Food System Summit Fails to Address Real Healthy and Sustainable Diets Challenges
por: Coutinho, Janine Giuberti, et al.
Publicado: (2021)

Woke Science and the 4th Industrial Revolution: Inside the Making of UNFSS Knowledge
por: Montenegro de Wit, Maywa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mbn509k019u46ba4guupbq4jeu